The presence of the H 2 S pathway in skeletal muscle (SKM) has recently been established. SKM expresses the three constitutive H 2 S-generating enzymes in animals and humans, and it actively produces H 2 S. The main, recognized molecular targets of H 2 S, that is, potassium channels and PDEs, have been evaluated in SKM physiology in order to hypothesize a role for H 2 S signalling. SKM dysfunctions, including muscular dystrophy and malignant hyperthermia, have also been evaluated as conditions in which the H 2 S and transsulfuration pathways have been suggested to be involved. The intrinsic complexity of the molecular mechanisms involved in excitation-contraction (E-C) coupling together with the scarcity of preclinical models of SKM-related disorders have hampered any advances in the knowledge of SKM function. Here, we have addressed the role of the H 2 S pathway in E-C coupling and the relative importance of cystathionine β-synthase, cistathionine γ-lyase and 3-mercaptopyruvate sulfurtransferase in SKM diseases.
Introduction
The function of skeletal muscle (SKM) is governed by a process known as excitation-contraction (E-C) coupling. This physiological phenomenon has intrigued many scientists since the XVIII century; however, only in the past 50 years have the molecular mechanisms involved, some structural components and the sequence of events required for muscle contraction been identified.
In the striated muscle, Ca 2+ release and uptake can be considered as the 'key point' of E-C coupling (Eshima et al., 2014) . We do not yet have a clear understanding of the molecular interactions that allow the E-C coupling signal; however, a macromolecular protein complex defined as a 'calcium release unit' has been identified (Dulhunty, 2006; Bellinger et al., 2008) . Skeletal isoforms of the dihydropyridine receptor, L-type Ca 2+ channel (Ca v 1.1) and ryanodine 1 receptor (RyR1) constitute the main structures of the 'calcium release unit', and their physical interaction is an essential requirement for E-C coupling in SKM (Dulhunty et al., 2002) . However, several other proteins are involved in the skeletal E-C coupling such as calmodulin, calstabin, A-kinase anchor protein, cAMP-dependent PKA, Ca
2+
/calmodulin-dependent protein kinase II and PDE4D3 (Bellinger et al., 2008; Arias-Calderon et al., 2016) . Dystrophin and syntrophin are also involved in the molecular machinery of E-C coupling. Indeed, their malfunctioning, due to an erroneous assembly, has been hypothesized as a cause of muscle fibre necrosis -one of the histological features typical of muscular dystrophies (Finkel et al., 2010; Flanigan, 2014) . Among the proteins involved in E-C coupling, RyR1 is probably the most studied; three mammalian genes, encoding the following different isoforms, have been identified: SKM RyR1, cardiac muscle ryanodine receptor (RyR2) and RyR3 that is not tissue-specific, but instead is widely expressed in the body Meissner et al., 1988 ; for details on RyR molecular structure, see Zalk et al., 2015) . Membrane depolarization triggers RyR1 opening with the consequent exit of Ca 2+ ions from the sarcoplasmatic reticulum to the cytosol increasing the intracellular Ca 2+ concentration from 10 À7 to 10 À5 M. This event leads to conformational changes that culminate in muscle contraction. In addition to cytosolic Ca 2+ concentration, many regulatory factors have been identified and/or suggested as modulators of RyR activity, among which is the redox status of the receptor. Indeed, within each subunit of the RyR molecular structure, there are 80-100 L-cysteine residues, and almost 20 of them are sensitive to chemical modification such as sulphydryl oxidation, S-nitrosylation or alkylation that can promote either activation or inhibition of RyR activity (Dulhunty et al., 2000; Pessah and Feng, 2000) . However, although all these studies strongly suggest that hyperreactive sulfhydryl moieties are an essential biochemical component of a transmembrane redox sensor in vitro, how much this phenomenon could influence Ca 2+ regulation in vivo and if its contribution varies between physiological and pathological conditions remains, as yet, unknown.
Hydrogen sulfide (H 2 S) signal transduction and potential molecular targets in SKM
H 2 S is the latest endogenous gasotransmitter to be discovered, and it is produced in several tissues and organ systems in animals and humans. It can be derived by both enzymatic and non-enzymatic pathways, although the non-enzymatic source accounts for only a minor portion of the H 2 S generated in the body. In mammals, H 2 S biosynthesis occurs in the cytosol and/or the mitochondria (see Wallace and Wang, 2015) , and it is provided by different enzymes widely expressed throughout the body (Table 1) . Cystathionine β-synthase (CBS) was the first H 2 S-generating enzyme to be discovered and is the best characterized. CBS protein is considered the main source of H 2 S in the CNS (Abe and Kimura, 1996; Eto and Kimura, 2002; Miles and Kraus, 2004) ; however, it is also abundantly expressed in peripheral tissues (Hosoki et al., 1997; Fiorucci et al., 2006; Szabo et al., 2013; Zhang et al., 2013; Bucci et al., 2014; Vellecco et al., 2016) . Cystathionine γ-lyase (CSE or CGL or CTH) is considered the main H 2 S-generating enzyme in the vasculature. As with CBS, CSE expression has been found in many locations in the body (Zhao et al., 2001; Fiorucci et al., 2006; Bucci et al., 2012; Vellecco et al., 2016; Cirino et al., 2017) . CBS and CSE are both pyridoxal-5-phosphate dependent enzymes, and they use the amino acid L-cysteine as a substrate (Kabil and Banerjee, 2014; Kimura, 2014) . Both proteins are involved in different reactions of the trans sulfuration pathway, some of which do not produce H 2 S (Kabil and Banerjee, 2014) . 3-Mercaptopyruvate sulfurtransferase (MPST) is the third H 2 S-generating enzyme; it is pyridoxal-5-phosphate-independent and needs 3-mercaptopyruvate as a substrate. MPST has been found in vasculature and in smooth muscle component of several organs (Nagahara et al., 1998; Shibuya et al., 2009; Modis et al., 2013; Vellecco et al., 2016) . The discovery of H 2 S as endogenous signalling molecule, and the localization of the enzymatic machinery responsible for its biosynthesis throughout the body, has prompted scientists to investigate the existence of an H 2 S pathway in SKM and to evaluate its role in both physiological and pathological conditions. Not much literature is available on this specific topic. Nevertheless, some studies have shown that SKM expresses the three constitutive enzymes responsible for H 2 S biosynthesis in rats (Chen et al., 2010; Du et al., 2013) and in humans (Islam et al., 2015; Vellecco et al., 2016) . In terms of relative expression, the amount of these three proteins in rat SKM is significantly less compared to the amounts in the liver and kidneys (Du et al., 2013) . Conversely, the amounts of H 2 S-generating enzymes in human SKM is comparable with those observed in the liver and kidneys (Islam et al., 2015) . In particular, by using fluorescent immunohistochemistry methods, Du et al. have found a different sub-localization of the enzymes within the rat muscle fibre. Indeed, CBS and MPST are mainly expressed in the endomysium and perimysium of SKM, whilst CSE is localized in the cytosol of the muscle fibre cells (Du et al., 2013) . However, the relative roles of each enzyme in muscle physiology and/or pathology has yet to be demonstrated. Unexpectedly, it has been shown that mouse SKM lacks all three enzymes (Chen et al., 2010; Veeranki and Tyagi, 2015) . Indeed, Veeranki et al. have shown that mouse SKM expresses methylenetetrahydrofolate reductase, an enzyme that participates in the re-methylation of homocysteine into methionine (see Figure 1 ), but it does not express CSE, CBS or MPST and, consequently, has a reduced L-cysteine and H 2 S content. The authors hypothesized that the lack of these enzymes makes mouse SKM prone to hyperhomocysteinaemia (HHcy)-induced myopathy (Veeranki and Tyagi, 2015) . However, further studies are needed to clarify this issue.
Activation of potassium channels
Being a gas, H 2 S travels freely across cell membranes activating various molecular targets in a receptor-independent manner. This characteristic allows this gasotransmitter to be considered as a mediator in many processes in both physiological and pathological conditions (Fiorucci et al., 2006; Lowicka and Beltowski, 2007; Szabo, 2007; Li et al., 2011; Cirino et al., 2017; Wallace and Wang, 2015) . Among the known cellular targets of H 2 S, potassium channels have been the first to be discovered. Activation of ATP-sensitive Table 1 Localization of H 2 S-generating enzymes
Enzymes Tissues References

CBS Brain
h, m, r Martin et al., 2009; Linden et al., 2008; Bronowicka-Adamska et al., 2017 Gastrointestinal tract h, m, r Martin et al., 2009; Linden et al., 2008 Heart m, r Testai et al., 2016; Nandi and Mishra, 2017 Kidney m, r Ahmad et al., 2016; Du et al., 2013 Liver h, m, r Ahmad et al., 2016; Du et al., 2013; Martin et al., 2009 Lung h, m, r Ahmad et al., 2016; Martin et al., 2009; Szczesny et al., 2016 Pancreas m, r Ahmad et al., 2016; Yusuf et al., 2005 Placenta h, m, r Hu et al., 2017; Patel et al., 2009; Sonne et al., 2013 Bucci et al., 2014; Bucci et al., 2012; Renga et al., 2015 MPST Brain h, m, r Tomita et al., 2016; Zhao et al., 2013; Bronowicka-Adamska et al., 2017 Gastrointestinal tract m, r Tomita et al., 2016; Magierowski et al., 2017 Heart m, r Tomita et al., 2016; Testai et al., 2016 Kidney m, r Tomita et al., 2016; Du et al., 2013 Liver h, m, r Tomita et al., 2016; Du et al., 2013; Li et al., 2017 Shibuya et al., 2009; Bucci et al., 2014; Kuo et al., 2016 Uro-genital tract m Aydinoglu et al., 2017 Tissue localization of H 2 S-generating enzymes (h = human; m = mouse; r = rat). The three enzymes involved in H 2 S biosynthesis are widely distributed in tissues of human (h), rat (r) and mouse (m). CBS, cystathionine β-synthase; CSE, cystathionine γ-lyase; MPST, 3-mercaptopyruvate sulfurtransferase.
potassium (K ATP ) channels (Zhao et al., 2001; Tang et al., 2005; Distrutti et al., 2006; Dawe et al., 2008; Jiang et al., 2010; Medeiros et al., 2012; Fitzgerald et al., 2014) , smalland intermediate-conductance calcium-activated potassium channels (SKCa channels and IKCa channels, respectively) (Tang et al., 2013 , Mustafa et al., 2011 Telezhkin et al., 2010; Li et al., 2010) and, more recently, voltage-dependent potassium (K V 7) channels (Martelli et al., 2013; Hedegaard et al., 2014) account for different biological functions of H 2 S in the cardiovascular, nervous, respiratory, gastrointestinal and endocrine systems. The activation of H 2 S-stimulated K ATP channels has been demonstrated by using a whole-cell patch-clamp technique and a mutagenesis approach: in colonic smooth muscle cells. H 2 S specifically Ssulfhydrates the sulfonylurea receptor 1 (SUR1) and SUR2B subunits of K ATP channels leading to an increased K ATP channel current (Jiang et al., 2010) . A similar mechanism of Ssulphydration of K ATP channels has also been shown in vascular smooth muscle cells where the increased amplitude of the K ATP channel current leads to hyperpolarization (Tang et al., 2005; Mustafa et al., 2009) . In mouse SKM sarcolemma, K ATP channels are very highly expressed (Flagg et al., 2010; MacIntosh et al., 2012) , and, despite the fact that their physiological function in SKM is not so clearly defined as in cardiac tissue, K ATP channel activation has been suggested to be involved in the prevention of calcium overload and preservation of myofibre integrity during exercise, as well as recovery from muscle fatigue, rather than in normal muscle contractility and excitability (Matar et al., 2000; MacIntosh et al., 2012) . Since H 2 S is actively produced in human SKM, and is detectable in nanomolar range (Vellecco et al., 2016) , it is feasible that H 2 S could modulate the activation of K ATP channels during muscle activity. As demonstrated in smooth muscles, it is possible that H 2 S induces K ATP channel activation through a mechanism involving S-sulfhydration. In this context, it is interesting to note that in patients susceptible to malignant hyperthermia (MHS), a syndrome characterized by a diffused hyper-contractility of SKM induced by volatile anaesthetics, the content of H 2 S in the vastus muscle is~10-fold higher compared to healthy subjects. The hyper-contractility in halothane-induced MHS is significantly reduced by glibenclamide, a selective blocker of K ATP channels (Vellecco et al., 2016) . This finding suggests that the increased amount of H 2 S detected in MHS subjects contributes to the anomalous contraction elicited by volatile anaesthetics. This hypothesis is corroborated by the finding that the mechanism of action of volatile anaesthetics involves the activation of several channels, including K ATP channels (Yoo et al., 2006; Matchett et al., 2009) . So it is feasible to speculate that in SKM of MHS subjects, there is a constitutive hyper-activation of K ATP channels due to increased levels of H 2 S. When these subjects are challenged with volatile anaesthetics, a state of 'over-activation' of K ATP channels takes place, contributing to the characteristic SKM hyper-contractility of MHS subjects. Other H 2 S molecular targets with a recognized role in the function of SKM are the sub-class of voltage-dependent potassium K v 7 channels. It is known that K v 7 channels are
Figure 1
Simplified scheme of transsulfuration pathway. The mammalians introduce the aminoacid methionine with the diet. The methionine could be converted into homocysteine and back to methionine. Homocysteine acts as a substrate leading to the synthesis of three major final products: H 2 S, taurine and glutathione. CAT, cysteine aminotransferase; CDO cysteine dioxygenase; CSAD, cysteine sulfonic acid decarboxylase; CSE, cystathionine γ-lyase; HDD, hypotaurine dyhydrogenase; MPST, 3-mercaptopyruvate sulfur transferase; MTHFR, methylenetetrahydrofolate reductase.
involved in resting membrane potential and electrical excitability control in many cell types included SKM (Miceli et al., 2008; Roura-Ferrer et al., 2008) . In particular, it has been shown that in mouse C 2 C 12 cells, K v 7.4 channels have a crucial role in the induction and/or maintenance of the differentiated state in skeletal myotubes (Iannotti et al., 2013) . The same group also demonstrated that K v 7 channels regulate the response of SKM to myotoxic stimuli, suggesting that K v 7 channel modulators have potential as new therapeutic agents for myopathies (Iannotti et al., 2010) . Recently, Martelli et al. have added K v 7 channels as new molecular targets for H 2 S (Martelli et al., 2013) . In particular, they showed that, in isolated mouse aorta, the vasorelaxing effect of NaHS (used as an exogenous source of H 2 S) is significantly inhibited by XE-991, a selective K v 7 channel blocker. In addition, exposure of human aortic smooth muscle cells to NaHS promotes membrane hyperpolarization to a similar extent to that observed for the selective K v 7 channel opener retigabine, and this effect was significantly antagonized by both selective blockers of K v 7 and K ATP channels (Martelli et al., 2013) . All these data could suggest a role for a H 2 S/K v 7 interaction in SKM function.
Phosphodiesterase inhibition
It has been demonstrated that in the vascular system, H 2 S acts as an endogenous non-selective inhibitor of the activity of PDEs (Bucci et al., 2010; Bucci et al., 2012; Coletta et al., 2012) . PDEs are a class of metalophosphohydrolases that, by hydrolyzing the cyclic nucleotides (cGMP and cAMP), regulate their physiological levels. H 2 S, by inhibiting the activity of PDEs, slows down the degradation rate of cyclic nucleotides modulating the transduction of downstream signals that involve cAMP and cGMP as second messengers. Within the vasculature, inhibition of PDE5, with the consequent increase in cGMP, is one of the main mechanisms of H 2 S-induced vasorelaxation (Bucci et al., 2010) . In SKM, different PDE isoforms have been found: PDE4(B,C,D), PDE7A and PDE8B, which selectively hydrolyze cAMP; PDE5A, which selectively hydrolyzes cGMP; and PDE11, which hydrolyzes both cyclic nucleotydes (Nio et al., 2017; Tetsi et al., 2017) . However, much more information is available on cAMP metabolism compared to cGMP in SKM (Stapleton et al., 2014; Nio et al., 2017) . Nevertheless, it has been shown that in mdx mice, the most widely used murine model of duchenne muscular dystrophy (DMD), treatment with the selective PDE5 inhibitor sildenafil reverses the cardiac dysfunction (Adamo et al., 2010) and reduces respiratory muscle weakness and fibrosis (Percival et al., 2012) , which are typical features of DMD. More recently, Nio et al. have shown that the treatment of mdx mice with piclamilast, a PDE4-selective inhibitor, also displays an antifibrotic effect and the combination therapy of piclamilast and sildenafil further increases the antifibrotic effect observed (Nio et al., 2017) . The evidence that, in SKM, H 2 S is actively produced and different isoforms of PDEs are constitutively expressed allows us to speculate that H 2 S, by inhibiting the activity of PDEs, could also modulate the level of cyclic nucleotides in SKM (see Figure 2 ).
Potential role of CBS and/or CSE in SKM dysfunctions
It is well established that the lack/impairment of CBS activity is the most common cause of hyperhomocysteinaemia (HHcy; for review see Morris et al., 2017) . HHcy represents a risk factor for several human diseases, and patients with HHcy manifest some characteristic features (early thrombotic events and cognitive decline) including SKM dysfunctions. As CBS is a H 2 S-generating enzyme, a deficiency in CBS provides a clear link between hydrogen sulfide and the pathophysiology of SKM. Indeed, several studies have correlated HHcy with SKM dysfunction. In 1976, Kanwar et al. showed that the SKM of patients with homocystinuria is characterized by anomalous collagen deposits in the basal lamina, which was associated with a disrupted Z-line (Kanwar et al., 1976) . This finding has been recently confirmed in a preclinical setting where chronic administration of homocysteine to rats caused a reduction in the viability of SKM cells and produced an energy imbalance (Kolling et al., 2013) . Also, some neurological pathologies that induce muscle degeneration, such as amyotrophic lateral sclerosis and multiple sclerosis,
Figure 2
Potential targets of hydrogen sulfide (H 2 S) in SKM. Different recognized, molecular targets of H 2 S that are expressed physiologically in SKM: ATPsensitive potassium (K ATP ) and voltage dependent (K V 7) channels. Several PDEs that are potential targets for H 2 S are also reported. Solid line: activation; dotted line: inhibition.
have been correlated with high levels of homocysteine in plasma and cerebrospinal fluids (Valentino et al., 2010; Zoccolella et al., 2012) . The molecular mechanisms of the deleterious action of homocysteine on SKM have not yet been clearly defined. It has been hypothesized that the availability of homocysteine in the muscle fibre is reduced due to the fact that it competes with the L-cysteine transporters (Veeranki and Tyagi, 2015) . Such a reduction in L-cysteine content not only affects the amount of H 2 S generated locally but also promotes oxidative stress, since L-cysteine is the precursor not only of H 2 S but also of glutathione and taurine, two of the main endogenous antioxidants (Stipanuk, 2004; Veeranki and Tyagi, 2015) . This mechanism has been shown to be present in a preclinical rat model of HHcy where an increase in ROS production was found to be associated with reduced glutathione levels (Kolling et al., 2013) . Similarly, a significant decrease in H 2 S content in muscle fibre, together with a decrease in SOD1 expression, is present in a rat model of SKM ischaemia-reperfusion (I-R) injury (Du et al., 2013) . These findings are associated with an increase in ROS (H 2 O 2 and O 2 À ) and malondialdehyde (MDA) production leading to severe necrosis, as revealed by histopathological analysis of the gastrocnemius muscle. It is noteworthy that pretreatment with NaHS decreases MDA content, reduces hydrogen peroxide and superoxide anion levels, but increases SOD activity and protein expression thereby protecting the SKM from oxidative stress (Du et al., 2013) . This latter finding strongly suggests that: (i) being an antioxidant molecule, H 2 S exerts a protective effect on SKM maintaining the physiological levels of oxidative products; (ii) the impairment of the endogenous production of H 2 S in SKM induces a disequilibrium in redox status with a consequent increase in ROS production that damages muscle fibres. The oxidative stress is further worsened by the reduction in SOD expression induced by I-R injury; and (iii) the exogenous administration of H 2 S not only regains the redox status but also restores SOD expression with the final effect of protecting SKM from oxidizing agents. In line with this view, it has been hypothesized that that a dysregulation of H 2 S metabolism is involved in chronic fatigue syndrome, also called myalgic encephalomyelitis (Dix Lemle, 2009 ). This is a very debilitating disease with an unknown aetiology and heterogeneous symptoms in terms of intensity, appearance and duration that makes diagnosis difficult (Collatz et al., 2016) . Post-exertional malaise, muscle and joint pain, difficulties with short-term memory, unrefreshing sleep, sore throat and headaches are some of a pattern of symptoms of this syndrome, often associated with dysregulation of body temperature and blood pressure (Collatz et al., 2016) . It has been suggested that a systemic dysfunction of H 2 S metabolism is the main cause of chronic fatigue syndrome. Such a dysregulation could explain the pattern of symptoms, apparently unconnected, typical of chronic fatigue syndrome (Dix Lemle, 2009) . A role of altered levels of H 2 S in SKM has been also present in SKM bundles harvested from MHS patients. In particular, molecular analysis shows that the main source of H 2 S in MHS patients is CBS that results strongly over-expressed, in terms of both protein and mRNA, compared to MHN. These evidence suggest that CBS-derived H 2 S is the main source of the 'pathological' high levels of H 2 S in MHS subjects (Vellecco et al., 2016) .
Another clue as to the role of H 2 S signalling in SKM function arises from the study by Ishii et al. (2010) . In this study, CSE À/À mice were generated as an animal model of cystathioninemia/cystathioninuria, a known autosomal recessive inborn error with increased plasma/urinary levels of cystathionine, with no pathological phenotype (Mudd et al., 2001) . The study shows that by feeding CSE À/À mice a low cysteine diet from 3 weeks old, an acute myopathy occurs, which is associated with a reduced concentration of glutathione in SKM and the liver. In more detail, once the low L-cysteine diet starts, the mice promptly lose weight whilst WT mice and CSE À/À mice fed a standard diet keep growing. Then, the mice display a paralysis of their lower extremities and severe atrophy in the abdominal regions, the trapezius and rectus femoris muscles. Thereafter, the mice become lame, paralysed in the upper extremities and finally die. Histological analysis of femur SKM sections of CSE À/À mice fed the low L-cysteine content revealed the intracellular accumulation of the autophagosomal marker LC3 and p62/sequestosome-1 in skeletal myofibres, suggesting enhanced autophagy leading to myopathic muscle loss (Masiero et al., 2009) . These findings strongly suggest a pivotal role for CSE in the development and function of SKM even though the exact contribution of this enzyme to the onset of myopathy is unknown.
Conclusions
Considering the enormous advances in life sciences made in recent decades, it is surprising, at least at first sight, how much there is still to clarify as regards SKM function. There are several hurdles to overcome: (i) SKM dysfunction ranges from generic muscle weakness and soreness to severe myopathy, muscle wasting and cachexia. Often, these signs are not directly correlated with a specific SKM disease, that is, muscular dystrophy, but rather constitute one symptom of a more complex syndrome that does not necessarily originate from SKM; (ii) despite the fact that many studies have been devoted to clarifying the molecular mechanisms involved in E-C coupling in vitro, the real impact of these mechanisms are very difficult to assess in vivo because of the intrinsic complexity of this phenomenon; and (iii) the information gleaned from animal models of muscle diseases does not always translate to human pathology. In addition, for many SKM human pathologies, a suitable animal model is still lacking. An interesting speculation that suggests a relevant role for the involvement of the L-cysteine/CSE-CBS/H 2 S pathway in the physiopathology of SKM relies on two findings that have been discussed within this review: (i) the lack of CSE genes, coupled with a low cysteine diet, induces an acute myopathy characterized by paralysis of the lower extremities and severe atrophy (Ishii et al., 2010) ; (ii) in human subjects susceptible to malignant hyperthermia, there is a hyper-contractility of SKM accompanied by an increased local production of H 2 S coupled with an overexpression of CBS (Vellecco et al., 2016) . Therefore, whilst a lack of CSE and the low availability of L-cysteine causes an impairment of the function of SKM, an increase in CBS expression and consequent enhanced production of hydrogen sulfide leads to muscle hyper-reactivity.
From this point of view, it appears clear that the murine model of DMD, that is, mdx mice, displays some similarities to CSE À/À mice fed a low cysteine content diet. Indeed, slow and progressive muscle weakness coupled with muscle degeneration are some of the features of mdx mice (Willmann et al., 2009; Manning and O'Malley, 2015; McGreevy et al., 2015) . This hypothesis is further supported by the study of Terrill et al. where it has been reported that the treatment of adult mdx mice with an L-cysteine precursor reduces the dystropathology and oxidative stress in these mice (Terrill et al., 2013) . Therefore, it is hypothesized that low levels of H 2 S (plasma or tissue levels) are an index of reduced SKM performance, whilst high levels are an index of hypercontractility/susceptibility. In conclusion, there is much to do in order to understand the role of hydrogen sulfide in the physiopathology of SKM. However, the nature of this gasotransmitter makes it an ideal player in the physiology of SKM, as among its targets there are channels and enzymes that are known to play an important role in the homeostasis of SKM.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from IUPHAR/BPS Guide to PHAR-MACOLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a,b) .
